TP53 and pancreatic neoplasm: As shown in Figure 2A, DS, used at 5 μM, in combination with SAHA, used at 2.5 μM, increased the expression level of acetylated p53 in PaCa44, pancreatic cancer cells carrying the p53 C176S mutation, whereas SAHA alone slightly induced this effect.